Edesa Biotech, Inc. ($EDSA)
Filing Information
| Accession Number | 0001171843-26-001267 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
60,587
Total Value
$99,175.55
P&L
+255.5% (+$253,440.79)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Feb 26, 2026 | Purchase | 20,571 | $1.58 | $32,479.55 | 615,797 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 2, 2026 | Grant/Award | 10,016 | $0.00 | $0.00 | 625,813 | Direct | โ | View Details | |
Director | Common Shares | โ | Feb 27, 2026 | Purchase | 30,000 | $2.22 | $66,696.00 | 371,702 | Indirect | Held by Pardeep Nijhawan Medicine Professional Corporation | View Details |